NewsBenzingaUBS mantiene il rating Neutral su Clover Health Investments, alza il prezzo obiettivo a 5,5 dollari UBS mantiene il rating Neutral su Clover Health Investments, alza il prezzo obiettivo a 5,5 dollari Benzinga 2026.11.06 00:20 (GMT+0) Open on Benzinga Other news Freedom Broker Downgrades Mastercard to Hold, Raises Price Target to $725 Key Overnight News Roundup (Nov 5 – Nov 6) Bitcoin, Ethereum, XRP, Dogecoin Bleed Amid Broader Sell-Off: Analyst Says BTC Will Bottom After Sweeping This Level Jones Trading Maintains Buy on Ellington Financial, Lowers Price Target to $13 Jones Trading Maintains Buy on Real REMAX Group, Lowers Price Target to $25.75 Jones Trading Maintains Buy on GEO Group, Raises Price Target to $42.75
Bitcoin, Ethereum, XRP, Dogecoin Bleed Amid Broader Sell-Off: Analyst Says BTC Will Bottom After Sweeping This Level
